Ankylosing Spondylitis Plasma
About: Ankylosing Spondylitis Plasma is collected from donors with clinically confirmed ankylosing spondylitis. Useful for analyzing circulating cytokines, inflammatory markers, and immune-modulating factors in autoimmune arthritis.
| Lot Number | Condition | Volume | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 77405 | Ankylosing Spondylitis | 1.0 ML | Hispanic/Latino | 43 | Female |
None Not taking any medications for hypertension.
|
16 | $495.00 | ||
| 77419 | Ankylosing Spondylitis | 1.0 ML | Caucasian | 46 | Male |
Duloxetine 60 mg QD Remicade Q8 weeks Methotrexate 7.5 mg QD Folic Acid 1 mg QD Modafinil 100 mg QD Olmesartan 40/25 mg QD Meloxicam 15 mg QD
|
13 | $495.00 | ||
| 77876 | Ankylosing Spondylitis | 1.0 ML | Caucasian | 62 | Male |
Taltz/80mg/mL/QM Celebrex/200mg/PRN ( has not taken it in long time) Sulfalsalizine QD
|
11 | $495.00 | ||
| 72201 | Ankylosing Spondylitis | 1.0 ML | Asian/Pacific Islander | 63 | Male |
Amitriptyline 100mg QD Sotyktu 6mg QD Atorvastatin 20 mg QD amlodipine 10mg QD Hydrochlorothiazide 25 mg QD
|
15 | $495.00 | ||
| 71615 | Ankylosing Spondylitis | 1.0 ML | Asian/Pacific Islander | 63 | Male |
Amitriptyline 100mg QD Sotyktu 6mg QD Atorvastatin 20 mg QD amlodipine 10mg QD Hydrochlorothiazide 25 mg QD
|
17 | $495.00 | ||
| 77504 | Ankylosing Spondylitis | 1.0 ML | African American | 67 | Female |
Gabapentin 100 mg TID Enulose Solution Eye Drops TID Timolol 1 gtt QD Kerendia 10 mg QD Adalimumab Injection Q 2 Weeks Rosuvastatin 20 mg QD Esomeprazole 40 mg QD Estradiol 0.1 mg Vaginal Cream Amlodipine-Olmesartan 20/40 mg QD
|
25 | $495.00 | ||
| 76540 | Ankylosing Spondylitis | 1.0 ML | Caucasian | 54 | Female |
Rosuvastatin 40 MG tablet, metoPROLOL succinate 25 MG 24 hr tablet, losartan 50 MG tablet, ezetimibe 10 MG tablet, fluoxetine 60 MG capsule Voquezna 20 MG Tab gabapentin 100 MG capsule Quetiapine 25 MG tablet Xeljanz XR 11 MG TABLET SR 24 HR Phentermine 37.5 mcg QD
|
25 | $495.00 | ||
| 71399 | Ankylosing Spondylitis | 1.0 ML | Caucasian | 82 | Male | United States (US) |
Celecoxib 200mg QD Gabapentin 600mg BID Atorvastatin 20mg QD Metoprolol 25mg QD Tamsulosin 0.4mg QD
|
8 | $495.00 | |
| 71582 | Ankylosing Spondylitis | 1.0 ML | Caucasian Hispanic/Latino | 46 | Male | United States (US) |
Tramadol 50 mg PRN
|
10 | $495.00 | |
| 71484 | Ankylosing Spondylitis | 1.0 ML | Caucasian | 23 | Male | United States (US) |
Naproxyn 500 mg QD
|
7 | $495.00 |
Ankylosing Spondylitis Plasma | High-Quality Human Plasma from Ankylosing Spondylitis Donors
Ankylosing Spondylitis Plasma is collected from donors clinically diagnosed with Ankylosing Spondylitis and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human plasma supports research focused on inflammatory pathways, immune profiling, and biomarker discovery in ankylosing spondylitis pathophysiology.
Product Features
- Research Use Only (RUO)
- Plasma collected from clinically confirmed Ankylosing Spondylitis donors
- Processed within one day of collection
- IRB-approved protocols and informed consent
- Custom aliquot volumes available upon request
De-identified Donor Data
- Verified Ankylosing Spondylitis diagnosis
- Demographic data: age, sex assigned at birth, race/ethnicity
- Donor-reported medications, allergies, and comorbidities
- Additional ankylosing spondylitis-specific metadata available
Applications
- Biomarker discovery and validation
- Cytokine and inflammation profiling
- Metabolomics and proteomics studies
- Therapeutic response research
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Ankylosing Spondylitis plasma is available in standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.
Protocols & Documentation
-
Download
Plasma Isolation
Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Plasma
Frequently Asked Questions
1 Answer
YES – Comprehensive medical records are available and may contain information regarding autoantibody status.
1 Answer
YES – Sanguine offers both inventory for select conditions, as well as, prospective collection. For inventory visit https://sanguinebio.com/products/plasma/?pro_inventory=inventory.
1 Answer
We never thaw our plasma samples before shipping.
1 Answer
Our standard aliquot size for plasma is 1 mL but we have bulk plasma (50 to 150 mL) available for select conditions. https://sanguinebio.com/product/human-bulk-plasma/
1 Answer
YES – Sanguine bio provides “age-matched healthy controls” and longitudinal studies capabilities.
1 Answer
YES – custom age specifications available – The “Specify I/E Criteria” service allows you to define specific age ranges for donor selection.
1 Answer
Age ranges available – Donor metadata includes age specifications, and you can specify inclusion/exclusion criteria. For pediatric samples specifically, contact learnmore@sanguinebio.com.
Ask a Question
Need a custom Plasma cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.